Sleep Apnoea Clinical Trial
Official title:
Abu Dhabi Sleep Apnea (ADSA) Study
Obstructive sleep apnoea (OSA) is a common medical problem which, despite increasing awareness, remains under-diagnosed. There is a close association between OSA and obesity; 60-70% of patients diagnosed with OSA are either obese or overweight [1]. OSA is also very common among patients with type 2 diabetes. Type 2 Diabetes Mellitus (T2DM) has reached epidemic status in the Gulf region. OSA worsens insulin resistance and leads to weight gain through sleep disturbance [2]. Several mechanisms have been proposed for the associations of OSA with diabetes and obesity [3]. At present there is little available information regarding the prevalence of OSA in the UAE, the relationship with T2DM and obesity, and the impact of OSA on health outcomes in the Emirati population. This research will explore these relationships and inform public health decisions regarding diagnostic pathways, service provision and treatment protocols.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02939586 -
The Effect of Haemodialysis in Sleep Apnoea
|
N/A | |
| Completed |
NCT03638895 -
Energy Expenditure From ECAL Indirect Calorimeter in a Multicomponent Weight Management Service
|
N/A | |
| Active, not recruiting |
NCT02615431 -
The Influence of MitraClip on Apnoea Asleep
|
N/A | |
| Completed |
NCT04071860 -
Developing a Non-contact Sleep Apnoea Detector, Suitable for Home Studies- The Safescan Study
|
||
| Completed |
NCT01861275 -
Ischaemic Stroke and Sleep Apnea in Northern Part of Finland
|
N/A | |
| Completed |
NCT00708786 -
Ventricular Arrhythmias Incidence According to Sleep Apnea Syndrome in Implantable Cardioverter-Defibrillator (ICD) Patients
|
Phase 4 |